openPR Logo
Press release

BET Inhibitors Exhibit an Emerging Pipeline with 35+ Drug Candidates

03-17-2017 10:58 AM CET | Health & Medicine

Press release from: P&S Market Research- Pharmaceuticals

BET Inhibitors Exhibit an Emerging Pipeline with 35+ Drug

BET inhibitors currently exhibit a strong pipeline with estimated 38 drug candidates.

BET inhibitors offer novel therapeutic approach for cancer

The study analyzed that the BET inhibitors pipeline comprised 38 drug candidates, of which 19 were in Pre-Clinical stage of development. The high prevalence of cancer across the globe fuels the extensive research and development for BET inhibitors. BET inhibitor constitutes that class of drugs, which prevents interactions between BET proteins, and transcription factors and acetylated histone. This results in immunosuppressive and anti-cancer properties of BET inhibitor. Inhibition of BET proteins offered a new therapeutic approach for the treatment of cancer, cardiovascular diseases and other diseases.

Browse the Report Summary at: www.psmarketresearch.com/market-analysis/bet-inhibitors-pipeline-analysis

Insights on pipeline segments

As per the findings of the research, around 16% of BET inhibitor drug candidates target BRD4 and 63% of the product candidates target BET. Other targets constituting 21% of candidates of the BET inhibitors pipeline include, but are not limited to, BRD2, BRD3, BRDT, Dual BET/DRD2, PI3K, super enhancer complex (SEC) and JAK2. Around 44% BET inhibitor pipeline drug candidates are being developed to be administered by oral route, and 3% by subcutaneous route.

IC50 value and Kd of different types of BET inhibitors

In BET inhibitors, IC50 value is measured as the concentration of drug at which 50% of the target is inhibited. IC50 is a pharmacokinetic measure; the lower the IC50 of drug candidate, the lesser the desired effect, and the less likelihood of the drug to have some off-target effect. Kd is known as dissociation constant of drug. It measures the rate of dissociation of the drug and its binding affinity. Birabresib (MK8628), a BET inhibitor by Merck & Co., has IC50 value of 100nM.

Browse Other Related Report at: www.psmarketresearch.com/industry-report/pharmaceuticals

Strategic collaborations for the development of BET inhibitors

The research finds that different companies are collaborating for the development of BET inhibitors. In January 2017, ConverGene entered into a sponsored research agreement with the University of Maryland, Baltimore. Under this agreement, University of Maryland School of Medicine Professor Curt I. Civin, M.D., who is associate dean for research and director of the Center for Stem Cell Biology & Regenerative Medicine, will investigate the in vivo anti-leukemic effects of ConverGene’s lead BET inhibitor drug candidates, CG223 and CG250. Some of the key players developing BET inhibitors are Resverlogix Corp., GlaxoSmithKline plc, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., AstraZeneca plc, Gilead Sciences, Inc., Zenith Epigenetics Ltd., and Incyte Corporation.

About P&S Market Research

P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.

As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.

Contact:
Abhishek
Executive – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: www.psmarketresearch.com

347, 5th Ave. #1402
New York City, NY - 10016

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BET Inhibitors Exhibit an Emerging Pipeline with 35+ Drug Candidates here

News-ID: 472151 • Views:

More Releases from P&S Market Research- Pharmaceuticals

Benign Prostatic Hyperplasia Therapeutics Market - Epidemiology Analysis, Therapy, Development, Growth and Demand Forecast to 2023
Benign Prostatic Hyperplasia Therapeutics Market - Epidemiology Analysis, Therap …
The global benign prostatic hyperplasia therapeutics market is expected to witness significant growth, as increased number of effective treatments are available for cancer. Increasing awareness regarding various cancer treatment drugs, technological advancements, and growing demand for safe and effective medications are acting as the major growth drivers for the benign prostatic hyperplasia therapeutics market. Globally, regulatory bodies are adding to the growth of the market with provision of funding, grants
Global Esophageal Cancer Therapeutics Market Analysis, Development and Demand Forecast to 2023
Global Esophageal Cancer Therapeutics Market Analysis, Development and Demand Fo …
Global esophageal cancer therapeutics market is expected to witness significant growth with an increasing awareness regarding cancer treatment and technological advancements. Also, high demand for safe and effective medications and rising prevalence of cancer are driving the growth of the global market. The regulatory bodies such as USFDA, EMA are supporting the growth of the global market by providing funding, designations and grants for speeding up the drug development process. Explore
Pancreatic Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Development and Demand Forecast to 2023
Pancreatic Cancer Therapeutics Market - Epidemiology Analysis, Therapy, Developm …
The global pancreatic cancer therapeutics market holds numerous opportunities for the key players, as pancreatic cancer is a highly challenging disease among all types of cancer, which has no specific treatment available for it, as of now. Also, growing incidence of cancer and technological advancements are supporting the growth of the global pancreatic cancer therapeutics market growth. Explore Report at: www.psmarketresearch.com/market-analysis/pancreatic-cancer-therapeutics-market Cancer instigates uncountable growth of cells due to some abnormalities
Novel Targets for Breast Cancer Treatment Drive Estrogen Receptor-Positive (ER+) Breast Cancer Pipeline Growth
Novel Targets for Breast Cancer Treatment Drive Estrogen Receptor-Positive (ER+) …
Estrogen Receptor-Positive (ER+) breast cancer currently exhibits a pipeline with 46 active drug candidates. ER+ breast cancer pipeline offers novel therapeutic targets for the treatment of breast cancer The study analyzed that the estrogen receptor positive breast cancer pipeline comprises approximately 74 drug candidates, of which nine products are in Phase III, 16 products in Phase II, 18 products in Phase I, and three products are in Pre-Clinical stage. The development of

All 5 Releases


More Releases for BET

Online Betting Market to Witness Huge Growth by 2026 | M-Bet, Premier Bet
A new statistical surveying study titled Online Betting Market investigates a few critical features identified with Online Betting Market covering industry condition, division examination, and focused scene. Down to earth ideas of the market are referenced in a straightforward and unassuming way in this report. A far-reaching and exhaustive essential investigation report features various actualities, for example, improvement factors, business upgrade systems, measurable development, monetary benefit or misfortune to support
Online Betting Market Study Along With Business Ideas, Development Trends and Ke …
Online Betting Market has recently added by Qurate Research to its vast repository. This intelligence report includes investigations based on Current scenarios, Historical records, and future predictions. Report includes overview, which interprets value chain structure, industrial environment, regional analysis, applications, market size, CAGR, Consumption, gross margin, diagrams, graphs and other substantial factors and forecast. The report is integrated with imperative insights on the market, which will support the clients to
Online Betting Market Next Big Thing | Major Giants M-Bet & Premier Bet
Global Online Betting Market Report 2020 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Online Betting Market. Some of the key players profiled in the study are M-Bet & Premier Bet. Online Betting Market
Online Betting Market 2020 Growth Factors, Opportunities, Ongoing Trends and Key …
The report attempts to offer a comprehensive analysis of the Online Betting Market status and development trends, including growth, opportunities, rising technology, competitive landscape, types, applications and product offerings of key players. Besides this, it contains a detailed analysis of the market scope, structure, potential, fluctuations, financial impacts, and also envelops the precise evaluation of market share, product & sales volume, and revenue. The findings of the study have been
Online Betting Market Regional Forecast 2020 | M-Bet, Premier Bet
According to this study, over the next five years the Online Betting market will register a xx% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. Global Online Betting Market 2020 by Marketandresearch.biz is an extensively researched and analyzed report on the market that will help market players to improve their business planning and ensure long-term success during
Online Betting Market Growth Prospects, Demand, Future Scenario and Key Vendors: …
Global Online Betting Market 2019 by Company Regions Type and Application Forecast to 2024 Online Betting is the wagering of money or something of value (referred to as "the stakes") on an event with an uncertain outcome with the primary intent of winning money or material goods. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The